DEXTROAMPHETAMINE SULFATE — all Canadian products
10 DINs
9 marketed/approved
1 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DEXTROAMPHETAMINE SULFATE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02481464 | APO-DEXTROAMPHETAMINE SR | APOTEX INC | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 10 MG | Approved | |
| 02481472 | APO-DEXTROAMPHETAMINE SR | APOTEX INC | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 15 MG | Approved | |
| 01924516 | DEXEDRINE | KNIGHT THERAPEUTICS INC. | Tablet | Oral | DEXTROAMPHETAMINE SULFATE 5 MG | Marketed | |
| 01924559 | DEXEDRINE SPANSULE | KNIGHT THERAPEUTICS INC. | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 10 MG | Marketed | |
| 01924567 | DEXEDRINE SPANSULE | KNIGHT THERAPEUTICS INC. | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 15 MG | Marketed | |
| 02443236 | DEXTROAMPHETAMINE | AA PHARMA INC | Tablet | Oral | DEXTROAMPHETAMINE SULFATE 5 MG | Marketed | |
| 02566605 | PMS-DEXTROAMPHETAMINE | PHARMASCIENCE INC | Tablet | Oral | DEXTROAMPHETAMINE SULFATE 5 MG | Approved | Yes |
| 02448327 | TEVA-DEXTROAMPHETAMINE SR | TEVA CANADA LIMITED | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 15 MG | Marketed | |
| 02448319 | TEVA-DEXTROAMPHETAMINE SR | TEVA CANADA LIMITED | Capsule (Sustained-Release) | Oral | DEXTROAMPHETAMINE SULFATE 10 MG | Marketed | |
| 02447673 | PMS-DEXTROAMPHETAMINE | PHARMASCIENCE INC | Tablet | Oral | DEXTROAMPHETAMINE SULFATE 5 MG | Cancelled Pre Market |
Browse other molecules: